11/11/2015 - 11:14am

Lead by incredible 60% growth in the brow segment, the eye category has been a bright spot for mass market retailers.

11/11/2015 - 11:14am

Shoppers hear, “It may help prevent diarrhea,” so they make the purchase. What they seldom understand is that probiotics are much more than just a diarrhea preventive. In fact, probiotics can be found in the ears, nose, mouth, lungs, urinary tract and more, and are linked to overall health, not just gastrointestinal health.

11/11/2015 - 11:14am

Skyn Condoms, a brand of Ansell Healthcare, is partnering with the Movember Foundation this month with a special “Movember Edition box.” Drug Store News spoke with Carol Carrozza, Ansell VP sales and marketing at TSE. Here’s what she had to say.

11/11/2015 - 11:13am

Birth rates are on the rise, according to the latest report from the Centers for Disease Control and Prevention. That’s good news for sellers of family planning test kits — overall sales of both pregnancy and ovulation test kits were up 2.2% to $364.8 million across total U.S. multi-outlets for the 52 weeks ended Sept. 6, according to IRI.

11/11/2015 - 11:13am

A new, dynamic diabetes-centric set co-created by Johnson & Johnson and Wakefern has the potential to generate $1,000 in incremental dollars for every new diabetes customer captured by Wakerfern’s ShopRite stores, the companies revealed recently at the GMDC Health Beauty Wellness 2015 conference in Phoenix.

11/11/2015 - 11:13am

Valeant Pharmaceuticals’ decision to raise the prices on a handful of drugs it has acquired over the past few years has led federal lawmakers and the Department of Justice to demand that the company explain its pricing policy.

11/11/2015 - 11:13am

A merger frenzy has hit the generics sector this year with a spate of acquisitions and hostile-takeover bids making headlines and reshaping the industry.

11/11/2015 - 11:13am

As 2015 draws to a close, the year is on track to be one in which the value of the branded drugs losing their patent protection approaches an all-time high. The dozens of drugs that will have lost their patent protection this year are estimated to have global sales of $44 billion a year — the highest total since $53 billion worth of medications went off patent in 2012.

11/11/2015 - 11:13am

Rapidly rising prices for many generics, regulations that could restrict patients’ access to these medications, a Food and Drug Administration backlog in getting new drugs approved and market consolidation that is reducing competition are all making some wonder how much longer generics will continue to be affordable.